Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions

NCT02231957

Last updated date
Study Location
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, New York, 10032, United States
Contact
1-800-718-1021

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Vaccination
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
11 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Parent with

1. adolescent aged 11-17 years;

2. adolescent with ≥1 chronic medical condition;

3. adolescent with clinic visit in last 12 months;

4. cell phone number listed in hospital registration system

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


Parent who:


1. does not speak English or Spanish;


2. is unwilling to receive text message vaccine reminders;


3. anticipates moving from area in coming 12 months

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

VaccinationText Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957
  1. New York, New York
ALL GENDERS
11 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title  ICMJE Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
Official Title  ICMJE Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
Brief Summary There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Health Services Research
Condition  ICMJE Vaccination
Intervention  ICMJE
  • Other: educational text message reminders
    Other Names:
    • educational text message vaccine reminders
    • education-embedded text message vaccine reminders
  • Other: conventional text message reminders
    Other Name: conventional text message vaccine reminders
Study Arms  ICMJE
  • Experimental: educational text message reminders
    receipt of education-embedded text message vaccine reminders
    Intervention: Other: educational text message reminders
  • Active Comparator: conventional text message reminders
    receipt of conventional text message vaccine reminders
    Intervention: Other: conventional text message reminders
Publications * Hofstetter AM, Barrett A, Camargo S, Rosenthal SL, Stockwell MS. Text message reminders for vaccination of adolescents with chronic medical conditions: A randomized clinical trial. Vaccine. 2017 Aug 16;35(35 Pt B):4554-4560. doi: 10.1016/j.vaccine.2017.07.022. Epub 2017 Jul 21.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: January 27, 2017)
416
Original Estimated Enrollment  ICMJE
 (submitted: September 2, 2014)
520
Actual Study Completion Date  ICMJE January 2017
Actual Primary Completion Date June 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

Parent with

  1. adolescent aged 11-17 years;
  2. adolescent with ?1 chronic medical condition;
  3. adolescent with clinic visit in last 12 months;
  4. cell phone number listed in hospital registration system

Exclusion Criteria:

Parent who:

  1. does not speak English or Spanish;
  2. is unwilling to receive text message vaccine reminders;
  3. anticipates moving from area in coming 12 months
Sex/Gender  ICMJE
Sexes Eligible for Study:All
Ages  ICMJE 11 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02231957
Other Study ID Numbers  ICMJE AAAM3756
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Annika Hofstetter, Columbia University
Study Sponsor  ICMJE Columbia University
Collaborators  ICMJE Pfizer
Investigators  ICMJE
Principal Investigator:Annika M Hofstetter, MD, PhD, MPHColumbia University
PRS Account Columbia University
Verification Date January 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP